这是一篇来自已证抗体库的有关人类 Bim的综述,是根据93篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Bim 抗体。
Bim 同义词: BAM; BIM; BOD

艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(Y36)
  • 免疫印迹; 人类; 图 4e
艾博抗(上海)贸易有限公司 Bim抗体(Abcam, ab32158)被用于被用于免疫印迹在人类样本上 (图 4e). elife (2019) ncbi
domestic rabbit 单克隆(Y36)
  • 免疫印迹; 人类; 1:1000; 图 5b
艾博抗(上海)贸易有限公司 Bim抗体(Abcam, ab32158)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5b). Front Neurosci (2019) ncbi
domestic rabbit 单克隆(Y36)
  • 免疫印迹; 人类; 1:2000; 图 4b
艾博抗(上海)贸易有限公司 Bim抗体(Abcam, ab32158)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 4b). Biosci Rep (2018) ncbi
domestic rabbit 单克隆(Y36)
  • 其他; 人类; 图 4c
艾博抗(上海)贸易有限公司 Bim抗体(Abcam, ab32158)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
domestic rabbit 单克隆(Y36)
  • 免疫印迹; 人类; 图 4
艾博抗(上海)贸易有限公司 Bim抗体(Abcam, ab32158)被用于被用于免疫印迹在人类样本上 (图 4). Braz J Med Biol Res (2017) ncbi
domestic rabbit 单克隆(Y36)
  • 免疫印迹; 人类; 图 2
艾博抗(上海)贸易有限公司 Bim抗体(Abcam, 32158)被用于被用于免疫印迹在人类样本上 (图 2). BMC Cancer (2016) ncbi
domestic rabbit 单克隆(Y36)
  • 免疫印迹; 大鼠; 1:200; 图 5
艾博抗(上海)贸易有限公司 Bim抗体(Abcam, ab32158)被用于被用于免疫印迹在大鼠样本上浓度为1:200 (图 5). Exp Ther Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 3g
艾博抗(上海)贸易有限公司 Bim抗体(Abcam, ab7888)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3g). Am J Physiol Lung Cell Mol Physiol (2016) ncbi
domestic rabbit 单克隆(Y36)
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司 Bim抗体(Abcam, ab32158)被用于被用于免疫印迹在人类样本上 (图 1). Neoplasia (2013) ncbi
圣克鲁斯生物技术
小鼠 单克隆(H-5)
  • 免疫印迹; 人类; 图 1e
圣克鲁斯生物技术 Bim抗体(Santa Cruz Biotechnology, sc-374,358)被用于被用于免疫印迹在人类样本上 (图 1e). Bioeng Transl Med (2021) ncbi
小鼠 单克隆(H-5)
  • 免疫印迹; 人类; 图 6d
圣克鲁斯生物技术 Bim抗体(Santa Cruz Biotechnology, H-5)被用于被用于免疫印迹在人类样本上 (图 6d). Sci Adv (2020) ncbi
小鼠 单克隆(H-5)
  • 免疫印迹; 人类; 1:500; 图 6a
圣克鲁斯生物技术 Bim抗体(Santa Cruz, sc-374358)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 6a). PLoS ONE (2017) ncbi
StressMarq Biosciences
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4c
StressMarq Biosciences Bim抗体(Stressmarq, SPC-113D)被用于被用于免疫印迹在人类样本上 (图 4c). Leukemia (2016) ncbi
Enzo Life Sciences
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2b
Enzo Life Sciences Bim抗体(Enzo, Farmingdale, ADI-AAP-330E)被用于被用于免疫印迹在人类样本上 (图 2b). Cell Death Dis (2021) ncbi
赛默飞世尔
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 7
赛默飞世尔 Bim抗体(Thermo Scientific, PA5-20089)被用于被用于免疫印迹在人类样本上 (图 7). Int J Pharm (2016) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 小鼠; 图 6c
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technology, 2933S)被用于被用于免疫印迹在小鼠样本上 (图 6c). PLoS Biol (2021) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 Bim抗体(CST, 2933S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). Cell Death Discov (2021) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 小鼠; 图 1d
赛信通(上海)生物试剂有限公司 Bim抗体(Cell signaling technology, 2933S)被用于被用于免疫印迹在小鼠样本上 (图 1d). Front Pharmacol (2021) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 大鼠; 1:1000; 图 6f
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technology, 2933T)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 6f). Cell Prolif (2021) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:1000; 图 1a
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technology, 2933)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1a). elife (2020) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 2n
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 2n). Cell Death Differ (2020) ncbi
domestic rabbit 单克隆(D7E11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 4585)被用于被用于免疫印迹在人类样本上. Cell Death Differ (2020) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹基因敲除验证; 人类; 1:1000; 图 5h, 5i
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹基因敲除验证在人类样本上浓度为1:1000 (图 5h, 5i). Nat Commun (2020) ncbi
domestic rabbit 单克隆(C34C5)
  • 流式细胞仪; 小鼠
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technology, C34C5)被用于被用于流式细胞仪在小鼠样本上. Nature (2019) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:500; 图 4a
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technology, 2933)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 4a). elife (2019) ncbi
domestic rabbit 单克隆(C34C5)
  • 流式细胞仪; 小鼠; 图 s2d
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 12186)被用于被用于流式细胞仪在小鼠样本上 (图 s2d). Cell Rep (2019) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:1000; 图 6c
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 6c). Oncogene (2019) ncbi
domestic rabbit 单克隆(C34C5)
  • 流式细胞仪; 小鼠; 图 s3e
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, C34C5)被用于被用于流式细胞仪在小鼠样本上 (图 s3e). Nature (2019) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 4f
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 4f). J Clin Invest (2019) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 小鼠; 图 s3i
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在小鼠样本上 (图 s3i). Science (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5c
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technology, 2819)被用于被用于免疫印迹在人类样本上 (图 5c). Blood Cancer J (2019) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫组化-石蜡切片; 人类; 图 3e
  • 免疫组化-石蜡切片; 小鼠; 图 6b
赛信通(上海)生物试剂有限公司 Bim抗体(CST, 2933)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3e) 和 被用于免疫组化-石蜡切片在小鼠样本上 (图 6b). Nat Commun (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s2b
赛信通(上海)生物试剂有限公司 Bim抗体(CST, 2819)被用于被用于免疫印迹在人类样本上 (图 s2b). Nat Commun (2019) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫组化; 小鼠; 1:400; 图 1a
  • 免疫印迹; 小鼠; 1:1000; 图 1e
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫组化在小鼠样本上浓度为1:400 (图 1a) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1e). Neuroscience (2019) ncbi
domestic rabbit 单克隆(C34C5)
  • 流式细胞仪; 小鼠; 图 3b
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, C34C5)被用于被用于流式细胞仪在小鼠样本上 (图 3b). J Immunol (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2819)被用于被用于免疫印迹在人类样本上 (图 3a). Oncotarget (2017) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:1000; 图 s4a
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s4a). Nat Med (2017) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 4c
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technology, 2933)被用于被用于免疫印迹在人类样本上 (图 4c). Nat Med (2017) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 4c
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technology, 2933)被用于被用于免疫印迹在人类样本上 (图 4c). Anticancer Res (2017) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 小鼠; 1:1000; 图 2c
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, C34C5)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 2c). Nat Commun (2017) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:1000; 图 8b
赛信通(上海)生物试剂有限公司 Bim抗体(cell signalling, 2933)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 8b). Int J Oncol (2017) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 s4k
赛信通(上海)生物试剂有限公司 Bim抗体(Cell signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 s4k). EMBO J (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1a
赛信通(上海)生物试剂有限公司 Bim抗体(cell signalling, 2819)被用于被用于免疫印迹在人类样本上 (图 1a). Cell Death Dis (2017) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100
  • 免疫印迹; 人类; 图 4d
赛信通(上海)生物试剂有限公司 Bim抗体(CST, 2819)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 和 被用于免疫印迹在人类样本上 (图 4d). Mol Ther (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 6c
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2819)被用于被用于免疫印迹在人类样本上 (图 6c). Br J Cancer (2017) ncbi
domestic rabbit 单克隆(C34C5)
  • 流式细胞仪; 小鼠; 图 6j
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, C34C5)被用于被用于流式细胞仪在小鼠样本上 (图 6j). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit 单克隆(C34C5)
  • 流式细胞仪; 小鼠; 图 3a
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, C34C5)被用于被用于流式细胞仪在小鼠样本上 (图 3a). J Exp Med (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司 Bim抗体(cell signalling, 4550)被用于被用于免疫印迹在人类样本上 (图 5a). PLoS Med (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5a
赛信通(上海)生物试剂有限公司 Bim抗体(cell signalling, 4581)被用于被用于免疫印迹在人类样本上 (图 5a). PLoS Med (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 2b
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, C34C5)被用于被用于免疫印迹在人类样本上 (图 2b). Biochem Biophys Res Commun (2017) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 s8d
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 s8d). Nature (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 4b
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933S)被用于被用于免疫印迹在人类样本上 (图 4b). Sci Rep (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 Bim抗体(cell signalling, 2819)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). Toxicol Appl Pharmacol (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 5f
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2819)被用于被用于免疫印迹在人类样本上 (图 5f). Cancer Res (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 1e
赛信通(上海)生物试剂有限公司 Bim抗体(cell signalling, 2819)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1e). Oncotarget (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司 Bim抗体(Cell signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 4). Oncotarget (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 流式细胞仪; 小鼠; 图 s2b
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, C34C5)被用于被用于流式细胞仪在小鼠样本上 (图 s2b). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 5b,5c,6b,6c,6d
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 5b,5c,6b,6c,6d). Oncotarget (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 1c
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 1c). Oncotarget (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 流式细胞仪; 小鼠; 1:200
  • 免疫印迹; 小鼠; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于流式细胞仪在小鼠样本上浓度为1:200 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3). Nat Commun (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2819)被用于被用于免疫印迹在人类样本上. elife (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:1000; 图 5
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Tech, 2933S)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5). Oncol Lett (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 流式细胞仪; 人类; 图 6
赛信通(上海)生物试剂有限公司 Bim抗体(cell signalling, C34C5)被用于被用于流式细胞仪在人类样本上 (图 6). J Clin Invest (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 3
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 3). Cancer Cell Int (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4a
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2819)被用于被用于免疫印迹在人类样本上 (图 4a). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫组化; 小鼠; 1:2000; 图 s1b
  • 免疫印迹; 小鼠; 1:2000; 图 s1b
  • 免疫印迹; 人类; 1:2000; 图 s1c
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2819)被用于被用于免疫组化在小鼠样本上浓度为1:2000 (图 s1b), 被用于免疫印迹在小鼠样本上浓度为1:2000 (图 s1b) 和 被用于免疫印迹在人类样本上浓度为1:2000 (图 s1c). Cell Death Differ (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 1c
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, C34C5)被用于被用于免疫印迹在人类样本上 (图 1c). Biochem Biophys Res Commun (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 小鼠; 1:1000; 图 1e
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 1e). Int J Cancer (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:1000; 图 1
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Tech, 2933)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1). Oncotarget (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 s6
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Tech, 2819S)被用于被用于免疫印迹在人类样本上 (图 s6). Sci Signal (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司 Bim抗体(Cell signaling, 2819)被用于被用于免疫印迹在人类样本上 (图 2). BMC Cancer (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 流式细胞仪; 小鼠
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, C34C5)被用于被用于流式细胞仪在小鼠样本上. Nature (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 6). Oncotarget (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 6
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 6). Front Genet (2015) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933S)被用于被用于免疫印迹在人类样本上 (图 4). Oncotarget (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, C34C5)被用于被用于免疫印迹在人类样本上 (图 1). Cancer Biol Ther (2016) ncbi
domestic rabbit 单克隆(D7E11)
  • 免疫组化; 小鼠; 1:400; 图 s6a
赛信通(上海)生物试剂有限公司 Bim抗体(Cell signaling, 4585)被用于被用于免疫组化在小鼠样本上浓度为1:400 (图 s6a). Cancer Res (2015) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 2d
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2819)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2d). Oncotarget (2016) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 7b
  • 免疫印迹; 小鼠; 图 s8
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 7b) 和 被用于免疫印迹在小鼠样本上 (图 s8). Oncotarget (2015) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:1000; 图 2
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technology, 2933)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫组化-石蜡切片; 人类
赛信通(上海)生物试剂有限公司 Bim抗体(CST, 2933)被用于被用于免疫组化-石蜡切片在人类样本上. Nature (2015) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 6b
赛信通(上海)生物试剂有限公司 Bim抗体(Cell signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 6b). Oncotarget (2015) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 3
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Tech, C34C5)被用于被用于免疫印迹在人类样本上 (图 3). Oncotarget (2015) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:5000; 图 4
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上浓度为1:5000 (图 4). Infect Immun (2015) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫组化-石蜡切片; 犬
  • 免疫印迹; 犬
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, C34C5)被用于被用于免疫组化-石蜡切片在犬样本上 和 被用于免疫印迹在犬样本上. Int J Oncol (2015) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:1000; 图 8
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technology, 2933)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 8). Oncotarget (2015) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司 Bim抗体(Cell signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 2). Pigment Cell Melanoma Res (2015) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上. J Biol Chem (2015) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上 (图 5). Biomed Res Int (2015) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3). Cancer Res (2014) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 小鼠; 1:1000; 图 6
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6). J Neurochem (2014) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technology, C34C5)被用于被用于免疫印迹在人类样本上. Cell Death Dis (2014) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, 2933)被用于被用于免疫印迹在人类样本上. Cell Death Dis (2014) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technology, 2933)被用于被用于免疫印迹在小鼠样本上. J Neurosci (2013) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 人类; 1:1000
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling Technologies, C34C5)被用于被用于免疫印迹在人类样本上浓度为1:1000. Cell Death Differ (2013) ncbi
domestic rabbit 单克隆(C34C5)
  • 免疫印迹; 小鼠
赛信通(上海)生物试剂有限公司 Bim抗体(Cell Signaling, C34C5)被用于被用于免疫印迹在小鼠样本上. Mol Cancer Ther (2013) ncbi
文章列表
  1. Carroll P, Freie B, Cheng P, Kasinathan S, Gu H, Hedrich T, et al. The glucose-sensing transcription factor MLX balances metabolism and stress to suppress apoptosis and maintain spermatogenesis. PLoS Biol. 2021;19:e3001085 pubmed 出版商
  2. Xu Y, Chen X, Pan S, Wang Z, Zhu X. TM7SF2 regulates cell proliferation and apoptosis by activation of C-Raf/ERK pathway in cervical cancer. Cell Death Discov. 2021;7:299 pubmed 出版商
  3. Ali A, Kuo W, Kuo C, Lo J, Chen M, Daddam J, et al. E3 ligase activity of Carboxyl terminus of Hsc70 interacting protein (CHIP) in Wharton's jelly derived mesenchymal stem cells improves their persistence under hyperglycemic stress and promotes the prophylactic effects against diabetic cardiac damages. Bioeng Transl Med. 2021;6:e10234 pubmed 出版商
  4. Hao L, Zhong W, Sun X, Zhou Z. TLR9 Signaling Protects Alcohol-Induced Hepatic Oxidative Stress but Worsens Liver Inflammation in Mice. Front Pharmacol. 2021;12:709002 pubmed 出版商
  5. Lake C, Voss K, Bauman B, Pohida K, Jiang T, Dveksler G, et al. TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8+ T cells in conjunction with CEACAM1. Cell Death Dis. 2021;12:400 pubmed 出版商
  6. Li Z, Meng Y, Liu C, Liu H, Cao W, Tong C, et al. Kcnh2 mediates FAK/AKT-FOXO3A pathway to attenuate sepsis-induced cardiac dysfunction. Cell Prolif. 2021;54:e12962 pubmed 出版商
  7. Arai S, Varkaris A, Nouri M, Chen S, Xie L, Balk S. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation. elife. 2020;9: pubmed 出版商
  8. Simula L, Corrado M, Accordi B, Di Rita A, Nazio F, Antonucci Y, et al. JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction. Cell Death Differ. 2020;: pubmed 出版商
  9. Bajpai R, Sharma A, Achreja A, Edgar C, Wei C, Siddiqa A, et al. Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. Nat Commun. 2020;11:1228 pubmed 出版商
  10. Aldonza M, Ku J, Hong J, Kim D, Yu S, Lee M, et al. Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms. Sci Adv. 2020;6:eaav7416 pubmed 出版商
  11. Wei J, Long L, Zheng W, Dhungana Y, Lim S, Guy C, et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576:471-476 pubmed 出版商
  12. Hagenbuchner J, Obsilova V, Kaserer T, Kaiser N, Rass B, Psenakova K, et al. Modulating FOXO3 transcriptional activity by small, DBD-binding molecules. elife. 2019;8: pubmed 出版商
  13. Wang L, Shen E, Luo L, Rabe H, Wang Q, Yin J, et al. Control of Germinal Center Localization and Lineage Stability of Follicular Regulatory T Cells by the Blimp1 Transcription Factor. Cell Rep. 2019;29:1848-1861.e6 pubmed 出版商
  14. Kabir S, Cidado J, Andersen C, Dick C, Lin P, Mitros T, et al. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells. elife. 2019;8: pubmed 出版商
  15. Sun B, Zhao X, Ming J, Liu X, Liu D, Jiang C. Stepwise detection and evaluation reveal miR-10b and miR-222 as a remarkable prognostic pair for glioblastoma. Oncogene. 2019;38:6142-6157 pubmed 出版商
  16. Di Pilato M, Kim E, Cadilha B, Prüßmann J, Nasrallah M, Seruggia D, et al. Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy. Nature. 2019;570:112-116 pubmed 出版商
  17. Pan C, Jin L, Wang X, Li Y, Chun J, Boese A, et al. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance. J Clin Invest. 2019;129:2431-2445 pubmed 出版商
  18. He M, Chaurushiya M, Webster J, Kummerfeld S, Reja R, Chaudhuri S, et al. Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1. Science. 2019;364:283-285 pubmed 出版商
  19. Dong H, Ye X, Zhong L, Xu J, Qiu J, Wang J, et al. Role of FOXO3 Activated by HIV-1 Tat in HIV-Associated Neurocognitive Disorder Neuronal Apoptosis. Front Neurosci. 2019;13:44 pubmed 出版商
  20. Zhu Y, Shi C, Bruins L, Wang X, Riggs D, Porter B, et al. Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4. Blood Cancer J. 2019;9:19 pubmed 出版商
  21. Haikala H, Anttila J, Marques E, Raatikainen T, Ilander M, Hakanen H, et al. Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy. Nat Commun. 2019;10:620 pubmed 出版商
  22. Hu K, Huang Q, Liu C, Li Y, Liu Y, Wang H, et al. c-Jun/Bim Upregulation in Dopaminergic Neurons Promotes Neurodegeneration in the MPTP Mouse Model of Parkinson's Disease. Neuroscience. 2019;399:117-124 pubmed 出版商
  23. Pan B, Wu L, Pan L, Yang Y, Li H, Dai Y, et al. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway. Biosci Rep. 2018;38: pubmed 出版商
  24. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  25. Mittelstadt P, Taves M, Ashwell J. Cutting Edge: De Novo Glucocorticoid Synthesis by Thymic Epithelial Cells Regulates Antigen-Specific Thymocyte Selection. J Immunol. 2018;200:1988-1994 pubmed 出版商
  26. Bogenberger J, Whatcott C, Hansen N, Delman D, Shi C, Kim W, et al. Combined venetoclax and alvocidib in acute myeloid leukemia. Oncotarget. 2017;8:107206-107222 pubmed 出版商
  27. Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed 出版商
  28. Vu L, Pickering B, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369-1376 pubmed 出版商
  29. Jelinek M, Kabelova A, Srámek J, Seitz J, Ojima I, Kovar J. Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells. Anticancer Res. 2017;37:1581-1590 pubmed
  30. Ahmed S, Macara I. The Par3 polarity protein is an exocyst receptor essential for mammary cell survival. Nat Commun. 2017;8:14867 pubmed 出版商
  31. Yokoyama T, Kohn E, Brill E, Lee J. Apoptosis is augmented in high-grade serous ovarian cancer by the combined inhibition of Bcl-2/Bcl-xL and PARP. Int J Oncol. 2017;: pubmed 出版商
  32. Wang X, Cao W, Zhang J, Yan M, Xu Q, Wu X, et al. A covalently bound inhibitor triggers EZH2 degradation through CHIP-mediated ubiquitination. EMBO J. 2017;36:1243-1260 pubmed 出版商
  33. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed 出版商
  34. Kong P, Zhu X, Geng Q, Xia L, Sun X, Chen Y, et al. The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer. Mol Ther. 2017;25:1027-1037 pubmed 出版商
  35. Mandl M, Zhang S, Ulrich M, Schmoeckel E, Mayr D, Vollmar A, et al. Inhibition of Cdk5 induces cell death of tumor-initiating cells. Br J Cancer. 2017;116:912-922 pubmed 出版商
  36. Knudson K, Pritzl C, Saxena V, Altman A, Daniels M, Teixeiro E. NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory quality. Proc Natl Acad Sci U S A. 2017;114:E1659-E1667 pubmed 出版商
  37. Hsu L, Cheng D, Chen Y, Liang H, Weiss A. Destabilizing the autoinhibitory conformation of Zap70 induces up-regulation of inhibitory receptors and T cell unresponsiveness. J Exp Med. 2017;214:833-849 pubmed 出版商
  38. Yang N, Liang Y, Yang P, Yang T, Jiang L. Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression. Braz J Med Biol Res. 2017;50:e5794 pubmed 出版商
  39. Laporte A, Barrott J, Yao R, Poulin N, Brodin B, Jones K, et al. HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma. PLoS ONE. 2017;12:e0169407 pubmed 出版商
  40. Li Y, Buijs Gladdines J, Cant Barrett K, Stubbs A, Vroegindeweij E, Smits W, et al. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study. PLoS Med. 2016;13:e1002200 pubmed 出版商
  41. Suzuki J, Nakajima W, Suzuki H, Asano Y, Tanaka N. Chaperone-mediated autophagy promotes lung cancer cell survival through selective stabilization of the pro-survival protein, MCL1. Biochem Biophys Res Commun. 2017;482:1334-1340 pubmed 出版商
  42. Kotschy A, Szlávik Z, Murray J, Davidson J, Maragno A, Le Toumelin Braizat G, et al. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016;538:477-482 pubmed 出版商
  43. Wang C, Zhang F, Cao Y, Zhang M, Wang A, Xu M, et al. Etoposide Induces Apoptosis in Activated Human Hepatic Stellate Cells via ER Stress. Sci Rep. 2016;6:34330 pubmed 出版商
  44. Wei R, Lin S, Wu W, Chen L, Li C, Chen H, et al. A microtubule inhibitor, ABT-751, induces autophagy and delays apoptosis in Huh-7 cells. Toxicol Appl Pharmacol. 2016;311:88-98 pubmed 出版商
  45. Horn T, Ferretti S, Ebel N, Tam A, Ho S, Harbinski F, et al. High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Res. 2016;76:6950-6963 pubmed
  46. Krepler C, Xiao M, Samanta M, Vultur A, Chen H, Brafford P, et al. Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma. Oncotarget. 2016;7:71211-71222 pubmed 出版商
  47. Bahr J, Robey R, Luchenko V, Basseville A, Chakraborty A, Kozlowski H, et al. Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget. 2016;7:69804-69815 pubmed 出版商
  48. Ladle B, Li K, Phillips M, Pucsek A, Haile A, Powell J, et al. De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation. Proc Natl Acad Sci U S A. 2016;113:10631-6 pubmed 出版商
  49. Pomares H, Palmeri C, Iglesias Serret D, Moncunill Massaguer C, Saura Esteller J, Núñez Vázquez S, et al. Targeting prohibitins induces apoptosis in acute myeloid leukemia cells. Oncotarget. 2016;7:64987-65000 pubmed 出版商
  50. Weyhenmeyer B, Noonan J, Würstle M, Lincoln F, Johnston G, Rehm M, et al. Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide. Oncotarget. 2016;7:61295-61311 pubmed 出版商
  51. Lai M, Gonzalez Martin A, Cooper A, Oda H, Jin H, Shepherd J, et al. Regulation of B-cell development and tolerance by different members of the miR-17∼92 family microRNAs. Nat Commun. 2016;7:12207 pubmed 出版商
  52. Sullivan K, Lewis H, Hill A, Pandey A, Jackson L, Cabral J, et al. Trisomy 21 consistently activates the interferon response. elife. 2016;5: pubmed 出版商
  53. Wang C, Ma Y, Hu Q, Xie T, Wu J, Zeng F, et al. Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumors. BMC Cancer. 2016;16:545 pubmed 出版商
  54. Bao H, Liu P, Jiang K, Zhang X, Xie L, Wang Z, et al. Huaier polysaccharide induces apoptosis in hepatocellular carcinoma cells through p38 MAPK. Oncol Lett. 2016;12:1058-1066 pubmed
  55. Liu M, Shan J, Li J, Zhang Y, Lin X. Resveratrol inhibits doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes. Exp Ther Med. 2016;12:1113-1118 pubmed
  56. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed 出版商
  57. Tagscherer K, Fassl A, Sinkovic T, Richter J, Schecher S, Macher Goeppinger S, et al. MicroRNA-210 induces apoptosis in colorectal cancer via induction of reactive oxygen. Cancer Cell Int. 2016;16:42 pubmed 出版商
  58. Zhao J, Niu X, Li X, Edwards H, Wang G, Wang Y, et al. Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells. Oncotarget. 2016;7:34785-99 pubmed 出版商
  59. Hornsveld M, Tenhagen M, van de Ven R, Smits A, van Triest M, van Amersfoort M, et al. Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer. Cell Death Differ. 2016;23:1483-92 pubmed 出版商
  60. Matsumoto M, Nakajima W, Seike M, Gemma A, Tanaka N. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells. Biochem Biophys Res Commun. 2016;473:490-6 pubmed 出版商
  61. Waldeck K, Cullinane C, Ardley K, Shortt J, Martin B, Tothill R, et al. Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model. Int J Cancer. 2016;139:194-204 pubmed 出版商
  62. Yu L, Wu W, Gu C, Zhong D, Zhao X, Kong Y, et al. Obatoclax impairs lysosomal function to block autophagy in cisplatin-sensitive and -resistant esophageal cancer cells. Oncotarget. 2016;7:14693-707 pubmed 出版商
  63. Kline C, van den Heuvel A, Allen J, Prabhu V, Dicker D, El Deiry W. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases. Sci Signal. 2016;9:ra18 pubmed 出版商
  64. Wang J, Goetsch L, Tucker L, Zhang Q, Gonzalez A, Vaidya K, et al. Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. BMC Cancer. 2016;16:105 pubmed 出版商
  65. Luo C, Liao W, Dadi S, Toure A, Li M. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Nature. 2016;529:532-6 pubmed 出版商
  66. Garg N, Tyagi R, Singh B, Sharma G, Nirbhavane P, Kushwah V, et al. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1. Int J Pharm. 2016;499:301-320 pubmed 出版商
  67. Lub S, Maes A, Maes K, De Veirman K, De Bruyne E, Menu E, et al. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells. Oncotarget. 2016;7:4062-76 pubmed 出版商
  68. Jin H, Gonzalez Martin A, Miletic A, Lai M, Knight S, Sabouri Ghomi M, et al. Transfection of microRNA Mimics Should Be Used with Caution. Front Genet. 2015;6:340 pubmed 出版商
  69. Dupont T, Yang S, Patel J, Hatzi K, Malik A, Tam W, et al. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma. Oncotarget. 2016;7:3520-32 pubmed 出版商
  70. Awad K, Elinoff J, Wang S, Gairhe S, Ferreyra G, Cai R, et al. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2016;310:L187-201 pubmed 出版商
  71. Nakajima W, Sharma K, Hicks M, Le N, Brown R, Krystal G, et al. Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer. Cancer Biol Ther. 2016;17:27-35 pubmed 出版商
  72. Momcilovic M, McMickle R, Abt E, Seki A, Simko S, Magyar C, et al. Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers. Cancer Res. 2015;75:4910-22 pubmed 出版商
  73. Ko T, Chin H, Chuah C, Huang J, Ng K, Khaw S, et al. The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia. Oncotarget. 2016;7:2721-33 pubmed 出版商
  74. Moncunill Massaguer C, Saura Esteller J, Pérez Perarnau A, Palmeri C, Núñez Vázquez S, Cosialls A, et al. A novel prohibitin-binding compound induces the mitochondrial apoptotic pathway through NOXA and BIM upregulation. Oncotarget. 2015;6:41750-65 pubmed 出版商
  75. Lauková J, Kozubík A, Hofmanová J, Nekvindová J, Sova P, Moyer M, et al. Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells. PLoS ONE. 2015;10:e0141020 pubmed 出版商
  76. Zhang L, Zhang S, Yao J, Lowery F, Zhang Q, Huang W, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527:100-104 pubmed 出版商
  77. Thijssen R, Ter Burg J, van Bochove G, de Rooij M, Kuil A, Jansen M, et al. The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells. Leukemia. 2016;30:337-45 pubmed 出版商
  78. Lavik A, Zhong F, Chang M, Greenberg E, Choudhary Y, Smith M, et al. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2. Oncotarget. 2015;6:27388-402 pubmed 出版商
  79. Heinemann A, Cullinane C, De Paoli Iseppi R, Wilmott J, Gunatilake D, Madore J, et al. Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling. Oncotarget. 2015;6:21507-21 pubmed
  80. Dille S, Kleinschnitz E, Kontchou C, Nölke T, Häcker G. In contrast to Chlamydia trachomatis, Waddlia chondrophila grows in human cells without inhibiting apoptosis, fragmenting the Golgi apparatus, or diverting post-Golgi sphingomyelin transport. Infect Immun. 2015;83:3268-80 pubmed 出版商
  81. Andersen N, Boguslawski E, Kuk C, Chambers C, Duesbery N. Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgrafts. Int J Oncol. 2015;47:71-80 pubmed 出版商
  82. Park J, Zhao L, Willingham M, Cheng S. Oncogenic mutations of thyroid hormone receptor β. Oncotarget. 2015;6:8115-31 pubmed
  83. Vogel C, Smit M, Maddalo G, Possik P, Sparidans R, van der Burg S, et al. Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK. Pigment Cell Melanoma Res. 2015;28:307-17 pubmed 出版商
  84. Rayavarapu R, Heiden B, Pagani N, Shaw M, Shuff S, Zhang S, et al. The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment. J Biol Chem. 2015;290:8722-33 pubmed 出版商
  85. Huang P, Hung S, Pao C, Wang T. N-(1-pyrenyl) maleimide induces bak oligomerization and mitochondrial dysfunction in Jurkat Cells. Biomed Res Int. 2015;2015:798489 pubmed 出版商
  86. Van Brocklyn J, Wojton J, Meisen W, Kellough D, Ecsedy J, Kaur B, et al. Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Res. 2014;74:5364-70 pubmed 出版商
  87. Eroglu B, Kimbler D, Pang J, Choi J, Moskophidis D, Yanasak N, et al. Therapeutic inducers of the HSP70/HSP110 protect mice against traumatic brain injury. J Neurochem. 2014;130:626-41 pubmed 出版商
  88. Nakajima W, Hicks M, Tanaka N, Krystal G, Harada H. Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer. Cell Death Dis. 2014;5:e1052 pubmed 出版商
  89. Pavet V, Shlyakhtina Y, He T, Ceschin D, Kohonen P, Perala M, et al. Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells. Cell Death Dis. 2014;5:e1043 pubmed 出版商
  90. Crowther A, Gama V, Bevilacqua A, Chang S, Yuan H, Deshmukh M, et al. Tonic activation of Bax primes neural progenitors for rapid apoptosis through a mechanism preserved in medulloblastoma. J Neurosci. 2013;33:18098-108 pubmed 出版商
  91. Geissler A, Haun F, Frank D, Wieland K, Simon M, Idzko M, et al. Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK. Cell Death Differ. 2013;20:1317-29 pubmed 出版商
  92. Ma T, Galimberti F, Erkmen C, Memoli V, Chinyengetere F, SEMPERE L, et al. Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer. Mol Cancer Ther. 2013;12:1545-55 pubmed 出版商
  93. Piazza R, Magistroni V, Mogavero A, Andreoni F, Ambrogio C, Chiarle R, et al. Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex. Neoplasia. 2013;15:511-22 pubmed